New Clinical Trial: Attention and Interpretation Modification (AIM) for Fear of Cancer Recurrence: An Intervention Development Study (NCT01517945)
WHY IT MATTERS
This trial addresses a common but often overlooked mental health challenge for cancer survivors—fear of recurrence—by testing a personalized, accessible mobile app intervention that could be widely available if proven effective.
Researchers at Memorial Sloan Kettering Cancer Center are testing a smartphone app designed to help breast cancer and rare cancer survivors deal with the fear that their cancer might come back. The app uses a technique called Attention and Interpretation Modification (AIM) to help people change how they think about cancer recurrence. The study has enrolled 252 people and is no longer recruiting new participants, but the results could help many cancer survivors in the future.
NCT ID: NCT01517945 Status: ACTIVE_NOT_RECRUITING Conditions: Breast Cancer, Rare Cancer Enrollment: 252 Sponsor: Memorial Sloan Kettering Cancer Center Summary: The purpose of this study is to test, customize, and personalize a mobile app-based intervention program in order to help rare and breast cancer survivors cope with fears of cancer recurrence.